Novel Breath Test to Detect Early Stage Chronic Pancreatitis
NCT01184573 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2014-02-10
Summary
The goal of this study is to evaluate the feasibility of using a non-invasive, non-radioactive Pancreatic Breath Test (PBT) as a diagnostic tool to detect early stages of chronic pancreatitis (CP). If successful, this method could have important advantages over existing diagnostic tests for detecting early stage CP. This diagnostic breath test may have a clinical impact if it leads to early detection of CP and intervention to mitigate disease progression.
Conditions
- Chronic Pancreatitis
Sponsors & Collaborators
-
University of Florida
collaborator OTHER -
Metabolic Solutions Inc.
lead INDUSTRY
Principal Investigators
-
Phillip P Toskes, MD · University of Florida at Gainesville
-
David A Wagner, PhD · Metabolic Solutions Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-05-31
- Primary Completion
- 2012-07-31
- Completion
- 2012-09-30
Countries
- United States
Study Locations
More Related Trials
-
Breath Condensate Study in Patients With Cystic Fibrosis.
NCT02056132 ·Status: COMPLETED
-
Measurement of Beta Cell Death in Individuals With Cystic Fibrosis
NCT03713437 ·Status: COMPLETED
-
Study of Metabolic Effects of Pregnancy in Women With Cystic Fibrosis
NCT00014768 ·Status: TERMINATED
-
Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis
NCT03140527 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Inhaled Bicarbonate on Airway pH in Cystic Fibrosis
NCT03391414 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of the CF Carrier State on the Kidneys and Pancreas
NCT05474417 ·Status: RECRUITING
-
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
NCT01851694 ·Status: RECRUITING ·Phase: NA
-
Imaging Airway Liquid Absorption in Cystic Fibrosis
NCT01486199 ·Status: COMPLETED ·Phase: NA
-
Utility of Induced Sputum Using Hypertonic Saline to Evaluate Infection and Inflammation in Cystic Fibrosis
NCT00721071 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis
NCT02510937 ·Status: COMPLETED ·Phase: PHASE1
-
Inhaled Bicarbonate Therapy in Cystic Fibrosis
NCT00177645 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis
NCT03375047 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency
NCT00157092 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
NCT02415959 ·Status: COMPLETED ·Phase: PHASE2
-
Malabsorption Blood Test:Toward a Novel Approach to Quantify Steatorrhea
NCT00572975 ·Status: COMPLETED ·Phase: PHASE4
-
Diabetes Therapy to Improve BMI and Lung Function in CF
NCT00072904 ·Status: COMPLETED ·Phase: PHASE3
-
β-cell Function and Insulin Sensitivity in Patients With Cystic Fibrosis
NCT04379726 ·Status: UNKNOWN
-
Regional Phenotyping of CF and Non-CF Bronchiectasis
NCT04793867 ·Status: RECRUITING
-
Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
NCT00510484 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Safety, Tolerability & Efficacy in Cystic Fibrosis Patients With Abnormal Glucose Tolerance
NCT02955888 ·Status: TERMINATED ·Phase: PHASE2
-
Repeatability and Response Study of Absorptive Clearance Scans
NCT01887197 ·Status: COMPLETED ·Phase: PHASE1
-
Exocrine Pancreatic Function Testing in Cystic Fibrosis
NCT01446861 ·Status: UNKNOWN
-
Study to Evaluate the Safety of CB-280 in Patients With Cystic Fibrosis
NCT04279769 ·Status: COMPLETED ·Phase: PHASE1
-
Molecular Phenotypes for Cystic Fibrosis Lung Disease
NCT01116414 ·Status: COMPLETED
-
Study to Assess the Safety and PK of Oral and IV Xenleta in Adults With Cystic Fibrosis
NCT05225805 ·Status: COMPLETED ·Phase: PHASE1